Tirzepatide
A synthetic peptide engineered as a dual GIP and GLP-1 receptor agonist. Utilized to investigate synergistic incretin receptor binding and its effects on intracellular cAMP production.
Price range: $65.00 through $155.00
Format: Lyophilized Powder
CAS Number: 2023788-19-2
Chemical Formula: Chemical Formula
Molecular Wt.: 4813.5 g/mol
Certificate of Analysis
View the latest third-party lab report for this batch. View COA
Storage Instructions
In lyophilized form, store at -20°C to 4°C. Keep away from light. If reconstituted, refrigerate.
Mandatory Disclaimer
For Research Use Only. Not for human or animal consumption.
Money Back Guarantee
Satisfaction Guarantee
Easy Returns
Secure Ordering
Product Features
- Synthetic dual GIP/GLP-1 receptor agonist
- High receptor affinity
- Enhanced molecular stability
- Suitable for in vitro preclinical research
- Greater than 99% pure HPLC
Products you may like
Retatrutide
A highly complex synthetic peptide acting as a triple agonist of the GIP, GLP-1, and Glucagon (GCGR) receptors. Utilized to…
Cagrilintide
A synthetic, long-acting amylin analogue. Utilized to investigate calcitonin and amylin receptor agonism, evaluating its role in satiety signaling and…
RetaCagri (Retatrutide + Cagrilintide)
A proprietary co-formulation combining a triple GIP/GLP-1/GCGR agonist with a long-acting amylin analogue. Utilized to investigate profound, multi-receptor metabolic signaling…
Semaglutide
A synthetic peptide engineered as a selective GLP-1 receptor agonist. Utilized to investigate incretin pathway activation, delayed gastric emptying models,…
